This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

BEY - Banner Image

Adverse reactions as per UK SmPC:

This product is subject to additional monitoring. 

Please refer to the full UK Summary of Product Characteristics for detailed safety warnings and information.

PP-BEY-GB-0012 | May 2025


    • 1
      UK Summary of Product Characteristics for BEYONTTRA (acoramidis)